Highwire is an extremely large, evolutionarily conserved E3 ubiquitin ligase that negatively regulates synaptic growth at the Drosophila NMJ. Highwire has been proposed to restrain synaptic growth by downregulating a synaptogenic signal. Here we identify such a downstream signaling pathway. A screen for suppressors of the highwire synaptic overgrowth phenotype yielded mutations in wallenda, a MAP kinase kinase kinase (MAPKKK) homologous to vertebrate DLK and LZK. wallenda is both necessary for highwire synaptic overgrowth and sufficient to promote synaptic overgrowth, and synaptic levels of Wallenda protein are controlled by Highwire and ubiquitin hydrolases. highwire synaptic overgrowth requires the MAP kinase JNK and the transcription factor Fos. These results suggest that Highwire controls structural plasticity of the synapse by regulating gene expression through a MAP kinase signaling pathway. In addition to controlling synaptic growth, Highwire promotes synaptic function through a separate pathway that does not require wallenda.
Introduction
The growth of new synaptic contacts shapes the initial development and subsequent refinement of neural circuits. Genetic studies have identified highwire as a highly conserved presynaptic regulator of synapse growth and morphology. In Drosophila, loss of highwire causes dramatic synaptic overgrowth of the neuromuscular junction (NMJ) (Wan et al., 2000) . In C. elegans, mutations in the homolog rpm-1 cause defects in the morphology, spacing, and number of presynaptic active zones (Schaefer et al., 2000; Zhen et al., 2000) . Mutations in the zebrafish homolog esrom disrupt retinotectal projections (D'Souza et al., 2005) , and deficiencies that remove the mouse homolog phr1 and neighboring genes result in altered NMJ development (Burgess et al., 2004) .
Highwire and its homologs are enormous proteins, ranging from 418 kDa in worms to 564 kDa in flies, and all share a series of domains that likely perform distinct biochemical activities. These include an N-terminal Ran GTP exchange factor-like domain that can inhibit adenylate cyclase (Pierre et al., 2004) , two PHR repeats of unknown function, a domain shown to bind the myc oncogene (Guo et al., 1998) , and a C-terminal RING finger that can function as an E3 ubiquitin ligase. The molecular function for each domain during synaptic growth is thus far unknown; however, the prevailing model for Highwire function focuses on its E3 ubiquitin ligase activity. The C. elegans homolog rpm-1 interacts with an SCF ubiquitin ligase complex (Liao et al., 2004) , and in both C. elegans and zebrafish the isolated RING domain can promote ubiquitination in vitro (D'Souza et al., 2005; Nakata et al., 2005) . In Drosophila, mutation of the C-terminal RING finger abolishes highwire function (Wu et al., 2005) . In addition, overexpression of ubiquitin hydrolases, which antagonize ubiquitination by removing ubiquitin from targeted proteins, promotes synaptic overgrowth and enhances the highwire phenotype (DiAntonio et al., 2001) . These results support a model in which Highwire restrains synaptic growth by downregulating levels of a signaling protein that promotes synaptic growth.
What is the target of Highwire regulation? In Drosophila, Highwire has been proposed to regulate a TGF-b signaling pathway through an interaction with co-SMAD Medea (McCabe et al., 2004) . However, in C. elegans, the homolog rpm-1 regulates a p38 MAP kinase signaling pathway (Nakata et al., 2005) and may also regulate the tyrosine kinase ALK (Liao et al., 2004) . Other candidate signaling pathways include cAMP metabolism in cultured neurons and rat spinal cord (Pierre et al., 2004) , tuberous sclerosis complex (TSC) signaling in cultured neurons and the fly eye (D'Souza et al., 2005; Murthy et al., 2004) , myc activity in cultured cells (Guo et al., 1998) , and pteridine biosynthesis in zebrafish . While Highwire may interact with all of these varied pathways, it is not known which pathway or pathways are essential for controlling synaptic growth.
Our unbiased approach to this question was to conduct a genetic screen in Drosophila for mutations that rescue the highwire synaptic overgrowth phenotype. The model for Highwire function predicts that the levels of a synaptogenic signaling protein would be increased in a highwire mutant. Therefore, genetically reducing the activity of such a protein should suppress the highwire synaptic overgrowth phenotype. In a genetic screen for such suppressors, we identified mutations in a single gene that we have named wallenda, which encodes a MAP kinase kinase kinase (MAPKKK) homologous to the vertebrate dual leucine zipper-bearing kinases DLK and LZK. Wallenda behaves as expected for a downstream target of Highwire. Both loss of highwire and overexpression of ubiquitin hydrolases cause dramatic increases in the level of Wallenda protein at synapses. wallenda is absolutely required for highwire-dependent synaptic overgrowth, and overexpression of wallenda is sufficient to cause synaptic overgrowth. Downstream of Wallenda, we find that the MAP kinase JNK and the transcription factor Fos are also essential for highwire synaptic overgrowth. Hence, Highwire controls synaptic growth by regulating a MAP kinase signal and its transcriptional output. The C. elegans Wallenda homolog DLK-1 is also required for the synaptic phenotypes of rpm-1 mutants (Nakata et al., 2005) . This evolutionary *Correspondence: dianton@molecool.wustl.edu conservation suggests that downregulation of a specific MAPKKK is a fundamental function for this large neuronal E3 ligase.
Results
A Genetic Screen for Mutations that Suppress the highwire Synaptic Overgrowth Phenotype At the Drosophila NMJ, mutations in highwire cause dramatic synaptic overgrowth (Wan et al., 2000; Wu et al., 2005) . This implies that Highwire normally functions to downregulate a pathway that mediates synaptic growth; in its absence, this downstream pathway is overactive. A prediction from this model is that the synaptic overgrowth could be suppressed by decreasing the activity of this downstream pathway. To find potential components of this pathway, we conducted a genetic screen for mutations that can dominantly suppress the highwire phenotype. Such a screen should identify genes whose dosage is important for synaptic overgrowth. To conduct a large-scale screen, we took advantage of the observation that combining loss-of-function mutations in highwire with overexpression of the ubiquitin hydrolase fat facets (faf) is lethal (DiAntonio et al., 2001 ). This lethality could arise from the overactivity of a downstream target normally regulated by ubiquitination. If so, then mutating this hypothesized downstream target should rescue lethality.
For the screen, flies carrying an upstream-activating sequence (UAS) promoter upstream of fat facets were chemically mutagenized and mated to highwire;elavGal4 virgins. Since highwire is on the X chromosome, all male offspring from this cross die because they are both mutant for highwire and overexpress fat facets in neurons. We screened over 20,000 mutagenized second and third chromosomes for suppression of lethality and found eighteen suppressors. Sixteen of these suppressors disrupt the fat facets gene, which was expected, since overexpression of nonfunctional fat facets is not lethal in combination with highwire (DiAntonio et al., 2001) . The two suppressor mutations that did not map to fat facets were candidate suppressors of highwire.
Genuine suppressors of highwire should not only suppress lethality, but should also suppress the cellular phenotype of synaptic overgrowth. Indeed, both mutations dominantly suppress the highwire synaptic morphology phenotype and, as transheterozygotes, completely suppress this phenotype (described in more detail below and in Figure 1 ). Both mutations map to a single locus on chromosome 3, and are phenocopied by deficiencies that delete this region (76B4-76D5). The mutations are therefore loss-of-function alleles of a single gene whose function is essential for the highwire synaptic overgrowth phenotype. We name this suppressor wallenda after the Flying Wallendas, an acrobat troupe famous for their world record stunts on the circus highwire.
wallenda Mutations Completely Suppress the highwire Synaptic Overgrowth Phenotype The ability of wallenda mutations to suppress the highwire synaptic morphology phenotype was characterized in detail ( Figures 1A-1I ) at the NMJ of muscle 4, which is formed from a single motoneuron, but similar results are observed at all glutamatergic type I NMJs ( Figures 1A-1C , lower panels). Mutations in highwire cause dramatic synaptic overgrowth: a 4-fold increase in the number of boutons ( Figure 1E ) and synaptic branches ( Figure 1F ) and a 2-fold increase in total synaptic area ( Figure 1G ). The highwire mutant phenotype also causes a 66% reduction in bouton size ( Figure 1H ) and a 70% reduction in the average intensity ( Figure 1I ) and a 50% reduction in total intensity (data not shown) of staining for synaptic vesicle proteins. For our analysis, we use DVGLUT as a representative synaptic vesicle marker, but similar effects are observed for synaptotagmin (data not shown). All of the above parameters of the highwire mutant phenotype are suppressed by mutations in wallenda (Figures 1E-1I ). Removing one copy of wallenda suppresses the highwire phenotype for each of these parameters by approximately 50% (p < 0.0001 for all parameters). Removing both copies of wallenda confers complete suppression. The highwire; wallenda double mutant (hiw ND8 ;wnd 1 /wnd 2 ) is not significantly different from wild-type (p > 0.9 for all parameters). Therefore, the wallenda gene is essential for the highwire synaptic overgrowth phenotype.
The allele of highwire used in Figure 1 (hiw ND8 ) contains a nonsense mutation in the N-terminal portion the protein (Wan et al., 2000) . However, some full-length Highwire protein can be detected in this mutant due to read-through of the premature stop codon (Wu et al., 2005) . To test whether suppression requires residual highwire activity, we generated deletions that remove either the N-terminal or C-terminal halves of the gene (Wu et al., 2005) . Both hiw DN and hiw DC can be suppressed by wallenda similarly to hiw ND8 (see Figure S1 in the Supplemental Data). These results rule out the possibility that wallenda functions as an upstream regulator of highwire, and instead support the model that wallenda functions downstream as an effector of the highwire synaptic overgrowth phenotype. In the absence of highwire, this downstream pathway is overactive. This pathway requires wallenda and is sensitive to its dose.
Comparison to Suppression by wit Mutants
It has been previously observed that mutations in the BMP/TGF-b signaling pathway can suppress highwire synaptic overgrowth, so we wished to compare this suppression to suppression by wallenda. Figure 1D shows suppression by mutations in the type II receptor wishful thinking (wit
). Additional alleles of wit that are genetic nulls are shown in Figure S2 . Several differences are of note. First, mutation of wit and other TGF-b pathway components cause a very strong reduction in synaptic growth (Aberle et al., 2002; Marques et al., 2002) in genetic backgrounds that are either wild-type or mutant for highwire (McCabe et al., 2004) . When highwire is wild-type, mutation of wit causes a dramatic reduction in bouton number (64%), branching (80%), and synaptic area (64%). In contrast, wallenda mutants show no reduction in synaptic growth in an otherwise wild-type background (p > 0.9 compared to wild-type for all parameters). Second, TGF-b mutants do not suppress the reduced bouton size or synaptic vesicle protein intensity phenotypes of highwire nearly as well as they suppress the bouton number phenotype of highwire (McCabe et al., 2004; Figures 1D, 1H , and 1I, and Figure S2 ). In contrast, wallenda mutations suppress all parameters of the highwire morphology phenotype completely. These differences suggest that wallenda and TGF-b mutants may suppress highwire through different mechanisms. Consistent with this, no dominant genetic interactions were observed between wallenda and mutations in wit or the co-SMAD medea.
wallenda Suppresses Synaptic Overgrowth Caused by Overexpression of fat facets The genetic interactions between loss-of-function mutations in the ubiquitin ligase highwire and gain-of-function mutations in the ubiquitin hydrolase fat facets suggest that both mutations may influence the same signaling pathway (DiAntonio et al., 2001) . To test this hypothesis we assessed whether wallenda can suppress fat facets-induced synaptic overgrowth. Neuronal overexpression of fat facets, like loss-of-function highwire, leads to an increased number of synaptic boutons and branches and an increased synaptic span ( Figure 1J , left panels). wallenda mutants suppress this phenotype ( Figure 1K , p < 0.0005). Therefore, wallenda is required for the overgrowth caused by both overexpression of a ubiquitin hydrolase and loss of a ubiquitin ligase. wallenda thus behaves genetically like a candidate substrate for ubiquitination that could mediate synaptic overgrowth.
wallenda Does Not Suppress the highwire Defect in Synaptic Function highwire mutants have defects in synaptic function as well as synaptic morphology. Since wallenda mutants can suppress the morphological defects of highwire, we tested whether wallenda mutants can also suppress the synaptic transmission defects of highwire. highwire mutants show both reduced quantal size (response to a single vesicle) and reduced quantal content (number of vesicles released by the nerve) ( Figure 2 , and see Wan et al., 2000; Wu et al., 2005) . wallenda mutants alone have normal synaptic function, allowing us to ask whether they could confer suppression to the highwire mutant phenotype. wallenda mutations do suppress the highwire defect in quantal size: both the amplitude and frequency of spontaneous miniature events in the highwire; wallenda double mutant are similar to wildtype (p > 0.9). In contrast, the evoked potentials of the highwire; wallenda double mutant are only modestly increased, and this is due entirely to the increased quantal size. The quantal content, calculated as the excitatory junction potential (EJP) amplitude divided by the miniature EJP (mEJP) amplitude, remains the same between highwire and highwire; wallenda (p > 0.9). Therefore, wallenda does not suppress the primary defect in highwire synaptic function, the reduced number of vesicles released by the nerve. While the quantal size phenotype of highwire may be secondary to the synaptic morphology phenotype, the defect in quantal content cannot be secondary to morphology. Therefore, highwire regulates synaptic physiology through a distinct molecular pathway that does not require wallenda.
wallenda is a Conserved MAPKKK The genetic results described above suggest that wallenda is a downstream target of highwire that functions to promote synaptic growth. Using meiotic recombination and deficiency mapping, wallenda was mapped to 76B4-76D5 on the third chromosome. This location was refined by male recombination mapping (Chen et al., 1998) to a 20 kb region at 76B9. Four annotated genes reside within this region, including the predicted kinase CG8789. Sequencing of both wallenda alleles revealed mutations in CG8789: wnd 1 has a mutation in a ;wnd 1 /wnd 2 ) larvae. Calibration: 20 ms, 5 mV for evoked release; 200 ms, 2 mV for spontaneous release. (B-D) For the same genotypes, the mean EJP amplitude (B), mEJP amplitude (C), and quantal content (D) are plotted. n > 11 cells for each genotype. In (C) the mEJP amplitude of hiw;wnd is not significantly different from wild-type (p > 0.9), and (*) is significantly increased compared to hiw (p < 0.0005), demonstrating that wallenda suppresses the highwire defect in quantal size. In (D), the quantal content of hiw;wnd is not significantly different than hiw (p > 0.9), demonstrating that wallenda does suppress the highwire defect in evoked release. Error bars = SEM.
conserved residue in the kinase domain, and wnd 2 has a mutation in the stop codon that adds an extra 104 amino acid tail to the protein ( Figure 3 ). We serendipitously found a third allele of wallenda, wnd 3 , in a highwire mutant line (hiw PF253 ) that showed heterogeneity in the synaptic overgrowth phenotype. We mapped the source of this heterogeneity to a suppressor mutation at the wallenda locus. This mutation of spontaneous origin behaves exactly like a new loss-of-function mutation in wallenda: wnd 3 can fully suppress the highwire synaptic overgrowth phenotype ( Figure S1 ). Sequencing revealed that wnd 3 contains a roo transposon insertion in the middle of the CG8789.
CG8789 belongs to the family of mixed lineage kinases that function as MAPKKKs for JNK and p38 signaling pathways. Its closest vertebrate homologs are the dual leucine zipper-bearing kinases DLK and LZK ( Figure 3 ) (Holzman et al., 1994; Sakuma et al., 1997) . Its similarity to these vertebrate kinases (63% identity in the kinase domain) is much greater than to its closest Drosophila relative, the mixed lineage kinase slipper (which shares only 29% identity in the kinase domain). Vertebrate DLK is expressed in neurons and has been observed to localize to synapses (Hirai et al., 2005; Mata et al., 1996) . The C. elegans homolog DLK-1 was identified as a suppressor of the highwire homolog rpm-1 (Nakata et al., 2005) . Hence, the regulation of this kinase is conserved between C. elegans and Drosophila.
Endogenous Wallenda Protein Localizes to Synapses and Is Regulated by Highwire
If wallenda functions downstream of highwire, it should be expressed in neurons where highwire function is required. In situ hybridization experiments in embryos detect wallenda transcript in the CNS at stage 13 and later, stages when axon guidance and synapse development take place (data not shown). To determine where Wallenda protein localizes, we raised polyclonal antisera in rabbits (WndA1) to a peptide near the C terminus (denoted in Figure 3 ). In embryos stage 13 and older, the aWallenda antibodies stain the neurite-and synapse-rich neuropil in the CNS. wnd 3 mutants show no neuropil staining, demonstrating the specificity of the antibodies ( Figures 4A and 4C ).
If wallenda is directly downstream of highwire then Highwire should regulate Wallenda protein levels. In embryos there is no significant difference in a-Wallenda staining between wild-type and highwire mutants (Figures 4A and 4C) . In contrast, loss of highwire dramatically alters Wallenda staining in ventral nerve cords of third-instar larvae ( Figures 4B and 4C ). In wild-type larvae Wallenda is barely detectable in the neuropil, although there is slightly more (16%) staining than in the wnd 3 mutant (p < 0.01). In highwire mutant larvae, Wallenda staining in the neuropil is dramatically increased. In addition, immunoblots of total protein extracts from dissected larval nerve cords demonstrate that mutation of highwire causes an increase in the total levels of Wallenda protein (2.5-fold, p < 0.01, Figures 4D and 4E) . The difference in Wallenda levels between embryos and larvae, and the differential effect of highwire mutations during these two stages, indicates that Highwire functions to control Wallenda primarily in larvae. This is consistent with the finding that Highwire functions throughout larval development to control synaptic growth (Wu et al., 2005) . Interestingly, this is the developmental period when the NMJ grows most dramatically (Schuster et al., 1996) .
The increase in Wallenda levels when the ubiquitin ligase Highwire is mutated suggests that Wallenda is regulated by ubiquitination. To test this model, we assayed the effects of overexpressing the ubiquitin hydrolases fat facets and yeast UBP2 on Wallenda. Neuronal overexpression of either hydrolase leads to dramatic increases in Wallenda staining in the neuropil, consistent with a role for ubiquitination in the downregulation of Wallenda ( Figures 4C and 4D ). Since overexpression of either of these ubiquitin hydrolases causes synaptic overgrowth (DiAntonio et al., 2001 ; Figure 1 ), there is a remarkable correlation between increased Wallenda levels and synaptic growth. Does Wallenda protein localize to the NMJ? Antibody staining in the CNS neuropil is consistent with a synaptic localization of Wallenda. Wallenda staining at the NMJ follows a similar trend to the neuropil staining. It is not reproducibly detectable in wild-type larvae, but when highwire is mutant or when the ubiquitin hydrolase UBP2 is driven in neurons, we detect Wallenda in distinct ), overexpressed fat facets [elav-Gal4, EP(3)381] and overexpressed UBP2 (elav-Gal4/UAS-UBP2) genotypes. Upper panels show Wallenda staining alone, and lower panels show costaining of Wallenda (green) with the synaptic marker NC82 (red). Scale bar, 25 mm. (C) Quantitation of average Wallenda staining in the neuropil of stage 16 embryos and third-instar larvae for the genotypes shown in (A) and (B); n = 6, 10, 21, 15, 16, 8, and 5, respectively. The Wallenda intensity was measured for each genotype and the background intensity measured for wnd 3 mutant embryos or larvae was subtracted (see Experimental Procedures). In embryos, Wallenda staining is not significantly different between wild-type and highwire mutant embryos (p > 0.9). In wild-type larvae, Wallenda staining is barely detectable above background levels (a 16% increase, p < 0.01). Mutations in highwire and overexpression of fat facets or UBP2 all cause a significant increase in Wallenda staining over the levels in wild-type (p < 0.005). 3 ), and overexpressed UBP2 (elav-Gal4/UAS-UBP2) genotypes. Wallenda is not detectable in wild-type larvae, but puncta within boutons ( Figure 4F ). Therefore, highwire affects the levels of Wallenda protein at the NMJ.
Highwire Can also Influence the Levels of Transgenic Wallenda Protein
The effect of highwire and fat facets on Wallenda staining is likely due to direct regulation of the Wallenda protein. However, it is formally possible that these mutants affect Wallenda indirectly by regulating wallenda gene expression. To test this possibility we expressed wallenda from a UAS-wnd transgene using the heterologous yeast UAS/Gal4 expression system (Brand and Perrimon, 1993) . However, in a highwire mutant background, expression of wallenda causes embryonic lethality. This observation supports the hypothesis that Highwire normally functions to counteract the activity of Wallenda. To circumvent this lethality we mutated a conserved residue (K188) in the kinase domain of the transgene to generate kinase-disrupted UAS-wnd KD . Mutation of the analogous lysine disrupts the kinase activity of mouse DLK (Mata et al., 1996; Xu et al., 2001 ). This transgene can be overexpressed robustly without causing death or other observable phenotypes. The kinase-mutated protein localizes to the NMJ ( Figure 4E ) and to CNS neuropil and cell bodies (data not shown). We could then ask whether removal of highwire affects the level of this transgenic protein. Indeed, loss of highwire results in a greater than 6-fold increase in levels of transgenic Wallenda at the NMJ (Figures 4E and 4F ). Wallenda staining in the CNS neuropil is also dramatically increased (data not shown). These results suggest that Highwire downregulates Wallenda protein. A similar result was observed with transgenic DLK-1 in C. elegans (Nakata et al., 2005) .
Wallenda is Sufficient to Confer Synaptic Overgrowth
The data thus far support the model that loss of highwire results in an overabundance of Wallenda protein, which causes synaptic overgrowth. To test whether overexpression of Wallenda is sufficient to cause synaptic overgrowth, we used a UAS-wnd cDNA transgene to overexpress Wallenda in motoneurons (see Experimental Procedures). Expression of the wallenda transgene results in synaptic overgrowth that is reminiscent of the highwire loss-of-function phenotype ( Figure 5 ). All the defects previously measured for the highwire lossof-function phenotype (in Figure 1) are reproduced by overexpression of Wallenda: bouton number ( Figure 5C ) and branching (data not shown, p << 0.001) are increased by over 4-fold, synaptic area is increased 2.5-fold (p < 0.005), bouton size ( Figure 5D ) and the average intensity of synaptic vesicle markers are reduced 4-fold ( Figure 5E ). Since expression of UAS-wnd KD gives no phenotype, the effects on synaptic growth are likely to require the kinase activity of Wallenda. Expression of UAS-wnd in postsynaptic muscles also results in no observable defects (data not shown). Hence, neuronal overexpression of the Wallenda kinase is sufficient to induce synaptic overgrowth.
Synaptic Overgrowth Requires JNK Signaling
Since Wallenda requires a wild-type kinase domain to promote synaptic growth, it likely functions through a MAP kinase signaling pathway. Wallenda belongs to a family of MAPKKKs known to activate p38 and JNK signaling (Gallo and Johnson, 2002) . In Drosophila there are two p38 genes, p38a and p38b, and a single JNK gene, basket (bsk). We tested whether either p38 or Bsk, reproducibly detected in puncta at NMJs of highwire mutant larvae. Upper panels show Wallenda staining alone (using the rabbit WndA1 antibody), and lower panels show costaining of Wallenda (green) with the neuronal marker HRP (red). Scale bar, 5 mm. , and (E) DVGLUT intensity for larvae that are wildtype (DVGLUT-Gal4/+), larvae that overexpress wallenda cDNA (UAS-wnd/+; DVGLUT-Gal4/+), and larvae that overexpress wallenda cDNA mutated in the kinase domain (UAS-wnd KD /+; DVGLUT-Gal4/+). n > 18 for all genotypes and all parameters. Neuronal overexpression of wallenda phenocopies highwire mutants for all measured parameters (p < 0.0001). Mutation of the kinase domain abolishes all wallenda gain-of-function phenotypes (p > 0.9 between wild-type and O/E wnd KD ). Error bars = SEM.
like Wallenda, is required for highwire-dependent synaptic overgrowth. To inhibit both genes for p38 in Drosophila, we combined a deletion for p38a (Craig et al., 2004 ) with a dominant-negative transgene for p38b (UAS-p38b DN ) that contains a mutation in the kinase domain and inhibits p38 function (Adachi-Yamada et al., 1999) . To inhibit bsk without disrupting its role in early embryonic development, we used a UAS-bsk DN transgene (Weber et al., 2000 ; denoted as JNK DN in Figure 6 ) that has a nonfunctional kinase domain. Both transgenes were expressed in a wild-type or highwire mutant background in postmitotic neurons using the BG380-Gal4 driver. Simultaneous inhibition of p38a and p38b does not suppress the highwire synaptic phenotype ( Figure 6C ). In contrast, inhibiting JNK signaling by expressing bsk DN (JNK DN ) suppresses the highwire phenotype ( Figure 6D ), reducing the number of synaptic boutons ( Figure 6G ) and branches and increasing bouton size and the intensity of synaptic vesicle markers (data not shown). The wallenda gain-of-function phenotype is similarly suppressed by bsk DN (Figures 6E-6G ). Hence, synaptic overgrowth in a highwire mutant requires JNK signaling.
Synaptic Overgrowth Requires the Fos Transcription Factor
JNK signaling affects many cellular processes, often by regulating transcription factor activity that leads to changes in gene expression. A common downstream effector of JNK-mediated changes in gene expression is the AP-1 complex of Fos and Jun transcription factors, which can regulate synaptic growth at the Drosophila NMJ (Sanyal et al., 2003) . To investigate whether Drosophila Fos or Jun (known as D-fos and D-jun, respectively) are required for highwire-dependent synaptic overgrowth, we inhibited each by expressing dominant-negative transgenes that contain the DNA binding and dimerization domains of Fos and Jun but lack the transcriptional activation domains (Eresh et al., 1997) . Expression of these dominant-negative transgenes in postmitotic neurons allowed us to circumvent early embryonic requirements for D-fos and D-jun (Kockel et al., 1997) .
When Fos DN and Jun DN are neuronally expressed in a wild-type background, there is a modest trend toward inhibition of synaptic growth, consistent with previous observations (Sanyal et al., 2003) . When expressed in a highwire mutant background, the Fos DN transgene confers dramatic suppression of the highwire synaptic phenotype ( Figures 7D and 7G) , reducing bouton number and branching (42%) and increasing the intensity of staining for synaptic vesicle markers at the synapse (2.2-fold, p < 0.0001). The reduction in highwire-dependent synaptic overgrowth is much greater than the reduction of growth in a wild-type background. In contrast, Jun DN does not suppress the highwire phenotype ( Figures 7C and 7G the highwire phenotype involves changes in gene expression rather than exclusively local changes to the synapse.
If Fos DN acts downstream of Wallenda to inhibit synaptic overgrowth, it should also suppress the synaptic overgrowth caused by overexpressing wallenda. Indeed, when Fos DN was coexpressed with UAS-wnd in neurons, Fos DN could suppress the wallenda gainof-function phenotype ( Figures 7E-7G ), leading to a 38% reduction in synaptic bouton number, a 52% reduction in synaptic branching, a 54% increase in bouton size, and a 3.8-fold increase in the intensity of staining of synaptic vesicle markers (p < 0.01 and n > 13 for all parameters). This is consistent with D-Fos acting downstream of Wallenda to promote synaptic growth. Therefore, the synaptic overgrowth phenotypes caused by loss of highwire and by overexpression of wallenda are similar in their requirements for the transcription factor D-Fos.
Discussion
Highwire is an extremely large, evolutionarily conserved protein that restrains synaptic growth at the Drosophila NMJ (Wan et al., 2000) . Current models suggest that Here we identify a MAPKKK, Wallenda, whose protein levels are controlled by Highwire and the activity of ubiquitin hydrolases. We demonstrate that Wallenda is both necessary for highwire-dependent synaptic overgrowth and sufficient to promote synaptic growth. Downstream of Wallenda, the MAP kinase JNK and transcription factor Fos are required for highwire-dependent synaptic overgrowth. We propose that Highwire restrains synaptic growth by downregulating the MAPKKK Wallenda, thereby inhibiting signaling through the JNK MAP kinase and the Fos transcription factor. In the absence of highwire, this signaling pathway is overactive, leading to changes in gene expression that result in excessive synaptic growth.
A Conserved Function for Highwire Is to Regulate the MAPKKK Wallenda
The regulation of the MAPKKK Wallenda is conserved from Drosophila to C. elegans (Nakata et al., 2005) . In both organisms, the synaptic phenotype of highwire/ rpm-1 requires the Wallenda/DLK-1 MAPKKK and downstream MAPK signaling. However, the downstream MAPK pathways diverge: in C. elegans, the rpm-1 phenotype requires a p38 MAP kinase (Nakata et al., 2005) , while the highwire phenotype requires JNK signaling. This suggests that regulation of the specific MAPKKK Wallenda/DLK-1, rather than a particular downstream MAP kinase pathway, is a fundamental activity of Highwire and its orthologs.
Since Highwire functions as an E3 ubiquitin ligase to restrain synaptic growth (Wu et al., 2005) , Wallenda is compelling candidate target. First, wallenda functions downstream of highwire and is essential for the synaptic overgrowth in highwire mutants. Second, increasing the levels of Wallenda by overexpression is sufficient to confer synaptic overgrowth. Third, Highwire regulates Wallenda protein levels through a posttranscriptional and most likely posttranslational mechanism. Each of the points above is conserved from Drosophila to C. elegans (Nakata et al., 2005) . Fourth, Wallenda protein levels are regulated by ubiquitination in vivo, since inhibiting ubiquitination by overexpressing ubiquitin hydrolases increases the levels of Wallenda protein. Fifth, the RING domain of the C. elegans homolog rpm-1 can interact with the Wallenda homolog DLK-1 and stimulate its ubiquitination when both are overexpressed in 293T cells (Nakata et al., 2005) .
Targeting a MAPKKK, which sits at the top of a MAP kinase signaling pathway, is an attractive mechanism for spatially and temporally controlling a synaptogenic signal without affecting downstream components shared by multiple MAPK signaling cascades. Restraining MAP kinase signaling is essential for controlling diverse cellular processes, including cell proliferation, differentiation, and apoptosis. The targeting of MAPKKKs by specific ubiquitin ligases may be a powerful and general mechanism for regulating MAP kinase signals (Laine and Ronai, 2005; Yamashita et al., 2005) .
While Wallenda is an essential mediator of the highwire mutant phenotypes in both Drosophila and C. elegans, an endogenous synaptic function for Wallenda has not yet been identified in either organism: the wallenda mutants have surprisingly normal synapse morphology and function. This may be due to another pathway that compensates for the loss of wallenda function. Such redundancy would obscure the role of wallenda. A second possibility is that wallenda functions in an aspect of synaptic growth that is not detected or required under laboratory culture conditions. For instance, wallenda could promote synaptic growth as part of a structural plasticity program that responds to unknown experience-dependent stimuli. A third possibility is that Wallenda does not normally function at synapses, but its upregulation in highwire mutants causes a neomorphic phenotype. In this scenario, the regulation of Wallenda by Highwire is required for normal synaptic development, but endogenous Wallenda would not itself regulate the synapse. The neuropil and synaptic localization of Wallenda and the vertebrate homolog DLK (Hirai et al., 2005; Mata et al., 1996) is, however, consistent with a synaptic function.
As an activator of MAP kinase signaling, Wallenda and its homologs might also control other processes beyond the synapse. Functional studies in vertebrates suggest that DLK and JNK signaling regulate neuronal migration and axon outgrowth in the developing cortex (Hirai et al., 2002) . Outside of the nervous system, DLK influences keratinocyte differentiation (Robitaille et al., 2005) , and LZK is highly expressed in the pancreas, liver, and placenta (Sakuma et al., 1997) . In Drosophila, we find that wallenda mutants are female sterile. We predict that the regulation of DLK and LZK is conserved from worms and flies to vertebrates. Therefore, the vertebrate homologs of Highwire might regulate some of these neuronal and/or extraneuronal developmental processes.
Multiple Functions for Highwire
Highwire is a large, multidomain protein that, in addition to acting as an E3 ubiquitin ligase, has been shown to inhibit adenylate cyclase, influence TSC signaling and pteridine biosynthesis, and interact with the myc oncogene and the co-SMAD Medea (Guo et al., 1998; Le Guyader et al., 2005; McCabe et al., 2004; Murthy et al., 2004; Pierre et al., 2004) . It is remarkable that throughout millions of years of evolution, members of the Highwire family have retained an exceptionally large size and complex domain structure. An attractive explanation for this conservation is that this molecule could serve as an intersection point for multiple signaling pathways, integrating MAP kinase and other signals during neural development.
The ubiquitin ligase activity alone could be responsible for regulating more than one downstream target. Interactions with components of TSC (tuberin/hamartin) and TGF-b signaling pathways suggest that Highwire might target either or both of these pathways (McCabe et al., 2004; Murthy et al., 2004) . The model that Highwire regulates TGF-b signaling through interaction with the co-SMAD Medea has received considerable attention. Since the TGF-b pathway regulates synaptic growth at the NMJ, it has been proposed that synaptic overgrowth of highwire mutants is caused by overactivity of this pathway (McCabe et al., 2004) . Null alleles of wit, which completely disrupt TGF-b signaling at the NMJ (Aberle et al., 2002; Marques et al., 2002) , can partially suppress the highwire phenotypes: they partially suppress the increase in bouton number, but show little or no suppression of the reduced bouton size and the reduced intensity for synaptic vesicle markers ( Figure 1 , Figure S2 ; McCabe et al., 2004) . This partial suppression of highwire by wit is consistent with the model that overactive TGF-b signaling contributes to the highwire phenotype. However, the data are also consistent with the alternate model that TGF-b signaling and Highwire act in parallel pathways. An assay for the activity of TGF-b signaling is to stain for phosphorylated-MAD (phospho-MAD), the major transducer of BMP signals in Drosophila, in motoneuron nuclei. We detected no change in the levels of phospho-MAD staining in highwire mutants compared to wild-type ( Figure S2 ). This assay is sensitive to changes in pathway activity-neuronal expression of the constitutively active type I receptor thick veins leads to a 40% increase in phospho-MAD staining (Figure S2) . Interestingly, this increase in TGF-b signaling does not lead to excess synaptic growth. Combining a highwire mutant with expression of constitutively active thick veins does cause excess growth (McCabe et al., 2004) , but it does not lead to any further increase in phospho-MAD staining ( Figure S2 ). These data are consistent with highwire and TGF-b signaling acting in parallel pathways.
Whether or not Highwire regulates TGF-b signaling, it is likely to target an additional pathway. Highwire not only restrains synaptic growth, but also promotes synaptic function. Synaptic function requires the ubiquitin ligase activity of Highwire (Wu et al., 2005) and is sensitive to the levels of the ubiquitin hydrolase fat facets (DiAntonio et al., 2001 ). Here we demonstrate that this regulation of neurotransmitter release does not require Wallenda. Therefore, Highwire must regulate at least two distinct molecular pathways. If Wallenda is a substrate whose downregulation is essential for restraining synaptic growth, there is likely another substrate for Highwire whose downregulation promotes neurotransmitter release.
Signaling Downstream of Wallenda
Highwire regulates synaptic growth via the MAPKKK Wallenda. Downstream of Wallenda, the JNK MAP kinase and Fos transcription factor are required for the highwire synaptic morphology phenotype. Therefore, Highwire attenuates a JNK signaling pathway that presumably controls gene expression to regulate synaptic growth. Previous studies have implicated JNK-dependent transcriptional control in activity-dependent growth of the Drosophila NMJ (Sanyal et al., 2003) . However, this previously described pathway is probably distinct from the JNK signal that is controlled by Highwire and activated by Wallenda. The previously described role for JNK requires AP-1, a heterodimer of Fos and Jun transcription factors; inhibiting either D-Fos or DJun disrupts this pathway. In contrast, highwire-induced overgrowth requires D-Fos, but not D-Jun. The Wallenda pathway could therefore involve a homodimer of D-Fos or another transcription factor that interacts with Fos. Such D-Jun-independent functions of D-Fos have been described previously in Drosophila Riesgo-Escovar and Hafen, 1997) . The differential requirement for transcription factors suggests that the output of Wallenda signaling cannot simply be activation of JNK, but instead activation of JNK in a particular spatial or temporal context, such as in the presence of cofactors that influence downstream signaling.
In addition to transcription factors, substrates for activated JNK include components of the cytoskeleton. Because the NMJ is distant from the motoneuron nucleus, and because vertebrate DLK colocalizes with tubulin in axonal regions of the brain (Hirai et al., 2005) , we initially expected that the Highwire/Wallenda/JNK pathway would influence synaptic morphology through local action upon the synaptic cytoskeleton. Instead, we identified a requirement for a transcription factor and presumably changes in gene expression. However, this does not exclude an interaction with the cytoskeleton or local changes at the synapse. It is possible that Highwire regulates the Wallenda signal in the cell body. However, the observation that Wallenda accumulates in the synapse-rich neuropil and at the NMJ when Highwire is absent suggests that Wallenda could become activated at the synapse. This would imply the need for a mechanism to transport the activated JNK signal back to the nucleus. In addition, cell-wide changes in gene expression must then be translated into localized growth at the synapse. Activated Wallenda at the synapse is an attractive candidate to integrate changes in gene expression with regulation of the synaptic cytoskeleton to control synaptic growth.
Experimental Procedures
Suppressor Screen Isogenic males carrying the homozygous EP(3)0381 transgene (containing the UAS promoter upstream of fat facets) were fed a solution of 5% sucrose and 22 mM methanesulfonic acid ethyl ester (EMS) (Sigma, St. Louis, MO) for 12-16 hr. These males were mated to hiw 1 ;elav-Gal4 virgin females. The F1 progeny of 600 independent crosses (corresponding to at least 20,000 mutagenized chromosomes) were screened for the presence of living adult males. Of the eighteen mutants found, sixteen failed to complement the recessive eye phenotype of faf Bx4 (Fischer-Vize et al., 1992) , indicating that they are alleles of faf. The other two suppressors are alleles of wallenda (wnd 1 and wnd 2 ). The third wallenda allele (wnd 3 ) was found in the strain background of hiw PF253 as a modifier of the highwire synaptic phenotype.
Mapping wallenda
The wallenda locus was mapped by meiotic recombination and deficiency mapping to 76B4-76D5. The map position was refined using male recombination (Chen et al., 1998) . Recombinants generated with GS5186 and with l(3)L1243 narrowed the locus to a region of 20 kb at 76B9 that contains CG8789.
Transgenic Wallenda Constructs A full-length cDNA for wallenda (CG8789) was obtained from Research Genetics (Clone ID: LD14856). The entire 4.3 kb cDNA fragment was subcloned into pUAST to generate the UAS-wnd transgene. To generate UAS-wnd KD , a conserved lysine in the kinase domain, K188, was changed to Ala using the Gene Editor in vitro Site-Directed Mutagenesis System (Promega, Madison, WI). Transformant lines were generated using standard techniques. Expression of UAS-wnd using the elav-Gal4 driver causes embryonic lethality. wallenda gain-of-function phenotypes were characterized using the panneuronal BG380-Gal4 driver (for Figures 6 and 7) and DVGLUT-Gal4 (for Figure 5) , which drives expression in motoneurons (R. Daniels and A.D., unpublished data) .
Fly Stocks
The following strains were used in this study: Canton S (wild-type), BG380Gal4 (neuron specific; Budnik et al., 1996) , elav-Gal4 (neuron specific; Yao and White, 1994) , DVGLUT-Gal4 (R. Daniels and A.D., unpublished data), MHC-Gal4 and G7-Gal4 (Zhang et al., 2001 ; muscle specific), EP(3)0381 (Rorth et al., 1998) , UAS-Bsk DN (Weber et al., 2000) , UAS-p38b DN (Adachi-Yamada et al., 1999) , Dp38a (Craig et al., 2004) , UAS-Fos DN (Fbz) and UAS-Fos DN (Jbz) (Eresh et al., 1997) , wit A12 and wit B11 (Harrison et al., 1995) , wit HA3 (Aberle et al., 2002) , Df(3L)C175 (Kulkarni et al., 1994) , UAS-activated Tkv (2D2) (Hoodless et al., 1996) , hiw DN (Wu et al., 2005) , and hiw alleles from (Wan et al., 2000) : hiw PF253 , hiw 1 , and hiw
ND8
.
Antisera to Wallenda
The rabbit a-Wallenda polyclonal antibody WndA1 was raised against a peptide corresponding to residues 798-811 in Wallenda gene product (-HSKRRKHPLGDNPN) by Zymed (San Francisco, CA). Antisera were affinity purified and used at a 1:100 dilution for immunocytochemistry.
Western Blots
Whole-cell extracts from dissected larval brains and ventral nerve cords were prepared as previously described (Wu et al., 2005) and run on 7% SDS-PAGE gels. Western blots were probed with WndA1 (1:100) or b-tubulin (1:1000) in PBS buffer containing 5% dry milk and 0.1% Tween-20.
Immunocytochemistry
To detect endogenous Wallenda, wandering third-instar larvae were dissected in ice-cold PBS and fixed in a PBS solution containing 3.7% formaldehyde for 1 to 1.5 hr on ice. Blocking and staining was performed in PBS containing 0.1% Triton-X. To reduce background staining, WndA1 antisera were preincubated with fixed embryos for >1 day at 4ºC and reused. For phospho-MAD staining, larvae were fixed in formaldehyde. For all other antibodies, larvae were fixed in Bouin's solution (a 1:5:15 ratio of acetic acid/formalin/picric acid) for 15 min. Other antibodies were used at the following dilutions: rabbit a-DVGLUT (Daniels et al., 2004) at 1:10,000, rabbit a-Syt (Mackler et al., 2002) at 1:5000, mouse monoclonal NC82 (Wagh et al., 2006) at 1:100, rabbit a-phospho-MAD (Tanimoto et al., 2000) at 1:5000, and mouse monoclonal BP102 (generated by Corey Goodman and obtained from the Developmental Studies Hybridoma bank) at 1:10. Cy3-conjugated goat a-HRP (Jackson Immunoresearch, West Grove, PA), and Cy3 488 (Jackson Immunoresarch) and Alexa 488 (from Molecular Probes, Invitrogen) conjugated a-rabbit and a-mouse secondary antibodies were used at 1:1000.
Imaging and Analysis
Images were acquired on a Nikon (Tokyo, Japan) C1 confocal microscope. Samples for each experiment were processed simultaneously with a wild-type control and imaged using the same confocal gain settings. All quantifications were performed while blinded to genotype. The muscle sizes for all larvae analyzed were similar. MetaMorph software (Molecular Devices, Sunnyvale, CA) was used for analysis of bouton size and synaptic area, and DVGLUT, Syt, and phospho-MAD intensity. Bouton size was determined by measuring the area of DVGLUT staining. Synaptic area was determined by measuring the area of continuous HRP staining that contained boutons so as to exclude nonsynaptic axonal HRP. The intensity of DVGLUT staining (or Syt staining) within this synaptic area was used to determine the average intensity of synaptic vesicle markers. We also measured the total intensity of DVGLUT in these images and observed a similar trend amongst genotypes to the average intensity. Statistical analysis was performed and graphs were generated using Origin 7.0 (Origin Lab, Northampton, MA).
Each sample was compared with other samples in the group using ANOVA.
Electrophysiology
Electrophysiological recordings were performed as previously described . Spontaneous mEJPs and evoked EJPs were recorded in 0.45 mM Ca 2+ Stewart saline (HL-3) (Stewart et al., 1994) . At least 60 consecutive spontaneous events were measured per cell using MiniAnal (Synaptosoft, Decatur, GA) and averaged to determine the mean mEJP. Quantal content was estimated by dividing the mean EJP by the mean mEJP. For all genotypes, the mean resting potentials and input resistances were similar, with average resting potentials of 271 +/23 mV and input resistances of 5.5 6 0.3 MU.
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